Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resveratrol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101481300B reveals a low-cost Perkin reaction route for trans-polyhydroxy diphenyl ethylene. Enhance supply chain reliability with high-purity pharmaceutical intermediates.
Novel patent CN120842292A offers shortened route for resveratrol glycosides. High purity beta-configuration suitable for osteoarthritis drug manufacturing.
Novel ionic liquid-mediated Heck coupling for trans-resveratrol. High yield, green process, cost-effective manufacturing for pharmaceutical intermediates.
Novel total synthesis of trans-resveratrol via Wittig-Horner. High yield, mild conditions, scalable production for pharmaceutical and nutraceutical applications.
Novel copper-catalyzed decarboxylation route for high-purity resveratrol and pterostilbene intermediates. Reduces steps and eliminates protection groups for cost-effective manufacturing.
Novel route for resveratrol and piceatannol via 1,2-diarylethanones offering cost reduction and high purity for pharmaceutical intermediates manufacturing.
Patent CN100368388C details a novel Knoevenagel synthesis for cyano-substituted resveratrol analogues, offering enhanced antitumor activity and scalable production for pharmaceutical intermediates.
Novel copper-catalyzed decarboxylation method for resveratrol. Reduces energy consumption and simplifies purification for reliable supply chain partners.
Novel industrial method for resveratrol preparation offering cost reduction and scalability for pharmaceutical intermediates manufacturing via efficient condensation.
Patent CN103664537B enables high-yield resveratrol production. Offers cost reduction in pharmaceutical intermediates manufacturing and reliable supply chain continuity.
Patent CN100368373C details a novel synthesis for carboxyl-substituted resveratrol analogs with superior antitumor activity, offering scalable manufacturing and cost-effective production for pharmaceutical applications.
Patent CN101117317B details a novel Heck reaction process for resveratrol. Discover cost-effective manufacturing and supply chain advantages for high-purity intermediates.
Patent CN101544591B discloses a mild Wittig-Horner route for (E)-substituted styrenes, offering cost-effective API intermediate manufacturing with high purity.
Patent CN102126931B details a scalable Horner-Wadsworth-Emmons route for Resveratrol, offering cost reduction and high purity for pharmaceutical manufacturing.
Patent CN105622350B reveals a three-step resveratrol synthesis avoiding protection groups. This method reduces costs and enhances supply chain reliability for pharmaceutical intermediates.
Patent CN106748662B reveals a high-yield synthetic route for Oxyresveratrol, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN113336788B details an efficient 7-step synthesis for resveratrol dimer bisphosphate derivatives, offering cost reduction and scalable manufacturing for osteoporosis drug intermediates.
Patent CN102276426A reveals a novel ligand-free Heck coupling method for trans-resveratrol. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Novel supramolecular method achieves >99.9% purity resveratrol by removing 3,4'-dihydroxystilbene. Green, scalable process for pharmaceutical intermediates.
Patent CN102180773B details a novel copper salt catalyzed route for resveratrol. This method reduces energy consumption and simplifies purification for reliable supply chains.